HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of uteroglobin in normal and carcinogenic endometrium and influence of hormone replacement therapy.

Abstract
Uteroglobin, first reported in 1968 as a steroid secreted in rabbit uterine fluid during early pregnancy, is a progesterone-regulated and progesterone-binding protein. There is evidence that indicates that uteroglobin is inversely correlated to neoplastic growth but its role to endometrial carcinogenesis is not known. Therefore we analyzed the expression of uteroglobin in 13 normal endometrium, 19 hyperplasia and 21 endometrial carcinoma samples and the relation to estrogen receptor-alpha (ER-alpha) and progesterone receptor (PR) by immunohistochemistry and Western blotting. We also analyzed the expression of uteroglobin in 15 menopausal women who received hormone replacement therapy (HRT). The expression of uteroglobin was higher during the secretory phase than in the proliferative phase; however, it was detected in endometrial hyperplasia as weakly as in the proliferative phase and decreased according to the loss of differentiation in endometrial carcinoma. The results were basically in accord with those for PR; however, the expression of uteroglobin was weak, though PR was most detected in endometrial hyperplasia. In menopausal endometrium, the group treated with estrogen plus progesterone exhibited higher expression of uteroglobin than the group treated only with estrogen. The evidence suggests that uteroglobin expression is regulated by progesterone in the normal endometrium but that the regulation by PR is lost in endometrial hyperplasia and carcinoma according to acquirement of tumorigenesis and that estrogen plus progesterone therapy reduces the risk for endometrial carcinoma by restoring uteroglobin.
AuthorsRyoichi Tanaka, Tsuyoshi Saito, Noriharu Shijubo, Masaki Takehara, Gen Yamada, Isao Kawabata, Yoshihisa Itoh, Ryuichi Kudo
JournalInternational journal of cancer (Int J Cancer) Vol. 109 Issue 1 Pg. 43-8 (Mar 2004) ISSN: 0020-7136 [Print] United States
PMID14735466 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2003 Wiley-Liss, Inc.
Chemical References
  • Estrogen Receptor alpha
  • Estrogens
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Progesterone
  • Uteroglobin
Topics
  • Blotting, Western
  • Carcinoma (metabolism)
  • Cell Differentiation
  • Cell Division
  • Endometrial Neoplasms (metabolism, prevention & control)
  • Endometrium (metabolism)
  • Estrogen Receptor alpha
  • Estrogens (metabolism)
  • Female
  • Hormone Replacement Therapy
  • Humans
  • Hyperplasia (pathology)
  • Immunohistochemistry
  • Menopause
  • Menstrual Cycle
  • Progesterone (metabolism)
  • Receptors, Estrogen (biosynthesis, metabolism)
  • Receptors, Progesterone (biosynthesis)
  • Uteroglobin (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: